These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 24548256)
61. Postinfectious irritable bowel syndrome. Barbara G; Cremon C; Pallotti F; De Giorgio R; Stanghellini V; Corinaldesi R J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S95-7. PubMed ID: 19300138 [TBL] [Abstract][Full Text] [Related]
62. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Crouzet L; Gaultier E; Del'Homme C; Cartier C; Delmas E; Dapoigny M; Fioramonti J; Bernalier-Donadille A Neurogastroenterol Motil; 2013 Apr; 25(4):e272-82. PubMed ID: 23433203 [TBL] [Abstract][Full Text] [Related]
63. Numb modulates the paracellular permeability of intestinal epithelial cells through regulating apical junctional complex assembly and myosin light chain phosphorylation. Yang Y; Chen L; Tian Y; Ye J; Liu Y; Song L; Pan Q; He Y; Chen W; Peng Z; Wang R Exp Cell Res; 2013 Dec; 319(20):3214-25. PubMed ID: 23872314 [TBL] [Abstract][Full Text] [Related]
64. Epithelial tight junctions in intestinal inflammation. Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319 [TBL] [Abstract][Full Text] [Related]
65. Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Ohman L; Simrén M Nat Rev Gastroenterol Hepatol; 2010 Mar; 7(3):163-73. PubMed ID: 20101257 [TBL] [Abstract][Full Text] [Related]
70. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815 [TBL] [Abstract][Full Text] [Related]
71. [The pathophysiology of irritable bowel syndrome: inflammation and motor disorder]. Park H Korean J Gastroenterol; 2006 Feb; 47(2):101-10. PubMed ID: 16498275 [TBL] [Abstract][Full Text] [Related]
72. Protease activated receptor 4 status of mast cells in post infectious irritable bowel syndrome. Han W; Wang Z; Lu X; Guo C Neurogastroenterol Motil; 2012 Feb; 24(2):113-9, e82. PubMed ID: 22151913 [TBL] [Abstract][Full Text] [Related]
73. Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos). Turcotte JF; Kao D; Mah SJ; Claggett B; Saltzman JR; Fedorak RN; Liu JJ Gastrointest Endosc; 2013 Apr; 77(4):624-30. PubMed ID: 23357497 [TBL] [Abstract][Full Text] [Related]
74. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Keszthelyi D; Troost FJ; Jonkers DM; Helyes Z; Hamer HM; Ludidi S; Vanhoutvin S; Venema K; Dekker J; Szolcsányi J; Masclee AA Eur J Pain; 2013 Oct; 17(9):1299-306. PubMed ID: 23529955 [TBL] [Abstract][Full Text] [Related]
75. Altered interaction between enteric glial cells and mast cells in the colon of women with irritable bowel syndrome. Meira de-Faria F; Casado-Bedmar M; Mårten Lindqvist C; Jones MP; Walter SA; Keita ÅV Neurogastroenterol Motil; 2021 Nov; 33(11):e14130. PubMed ID: 33797165 [TBL] [Abstract][Full Text] [Related]
76. Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Demaude J; Salvador-Cartier C; Fioramonti J; Ferrier L; Bueno L Gut; 2006 May; 55(5):655-61. PubMed ID: 16299034 [TBL] [Abstract][Full Text] [Related]
77. Neuroimmune interactions at different intestinal sites are related to abdominal pain symptoms in children with IBS. Di Nardo G; Barbara G; Cucchiara S; Cremon C; Shulman RJ; Isoldi S; Zecchi L; Drago L; Oliva S; Saulle R; Barbaro MR; Stronati L Neurogastroenterol Motil; 2014 Feb; 26(2):196-204. PubMed ID: 24304324 [TBL] [Abstract][Full Text] [Related]
78. T-cell activation in patients with irritable bowel syndrome. Ohman L; Isaksson S; Lindmark AC; Posserud I; Stotzer PO; Strid H; Sjövall H; Simrén M Am J Gastroenterol; 2009 May; 104(5):1205-12. PubMed ID: 19367268 [TBL] [Abstract][Full Text] [Related]
79. New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond. Sinagra E; Morreale GC; Mohammadian G; Fusco G; Guarnotta V; Tomasello G; Cappello F; Rossi F; Amvrosiadis G; Raimondo D World J Gastroenterol; 2017 Sep; 23(36):6593-6627. PubMed ID: 29085207 [TBL] [Abstract][Full Text] [Related]
80. [Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope]. Kong WM; Gong J; Dong L; Chen MX Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1167-70, 1172. PubMed ID: 17715017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]